Display options
Cite
Akwo EA, Robinson-Cohen C, Chung CP, et al. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension. 2021;78(2):376-386doi: 10.1161/HYPERTENSIONAHA.120.16181.
Akwo, E. A., Robinson-Cohen, C., Chung, C. P., Shah, S. C., Brown, N. J., Ikizler, T. A., Wilson, O. D., Rowan, B. X., Shuey, M. M., Siew, E. D., Luther, J. M., Giri, A., Hellwege, J. N., Velez Edwards, D. R., Roumie, C. L., Tao, R., Tsao, P. S., Gaziano, J. M., Wilson, P. W. F., O'Donnell, C. J., Edwards, T. L., Kovesdy, C. P., Hung, A. M. (2021). Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension (Dallas, Tex. : 1979), 78(2), 376-386. https://doi.org/10.1161/HYPERTENSIONAHA.120.16181
Akwo, Elvis A, et al. "Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program." Hypertension (Dallas, Tex. : 1979) vol. 78,2 (2021): 376-386. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.16181
Akwo EA, Robinson-Cohen C, Chung CP, Shah SC, Brown NJ, Ikizler TA, Wilson OD, Rowan BX, Shuey MM, Siew ED, Luther JM, Giri A, Hellwege JN, Velez Edwards DR, Roumie CL, Tao R, Tsao PS, Gaziano JM, Wilson PWF, O'Donnell CJ, Edwards TL, Kovesdy CP, Hung AM. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension. 2021 Aug;78(2):376-386. doi: 10.1161/HYPERTENSIONAHA.120.16181. Epub 2021 Jun 21. PMID: 34148359; PMCID: PMC8364328.
Copy Download .nbib Format: NLM
Share it on

Hypertension. 2021 Aug;78(2):376-386. doi: 10.1161/HYPERTENSIONAHA.120.16181. Epub 2021 Jun 21.

Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.

Hypertension (Dallas, Tex. : 1979)

Elvis A Akwo, Cassianne Robinson-Cohen, Cecilia P Chung, Shailja C Shah, Nancy J Brown, T Alp Ikizler, Otis D Wilson, Bryce X Rowan, Megan M Shuey, Edward D Siew, James M Luther, Ayush Giri, Jacklyn N Hellwege, Digna R Velez Edwards, Christianne L Roumie, Ran Tao, Phil S Tsao, J Michael Gaziano, Peter W F Wilson, Christopher J O'Donnell, Todd L Edwards, Csaba P Kovesdy, Adriana M Hung,

Affiliations

  1. Division of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
  2. Vanderbilt Center for Kidney Disease (E.A.A., C.R.-C., T.A.I., E.D.S., A.M.H.).
  3. Tennessee Valley Healthcare System, Nashville, VA (E.A.A., C.R.-C., C.P.C., S.C.S., T.A.I., O.D.W., E.D.S., A.M.H.).
  4. Division of Rheumatology, Department of Medicine (C.P.C.), Vanderbilt University Medical Center, Nashville, TN.
  5. Vanderbilt Genetics Institute (C.P.C., A.G., R.T.).
  6. Division of Gastroenterology, Hepatology and Nutrition (S.C.S.), Vanderbilt University Medical Center, Nashville, TN.
  7. Department of Medicine (N.J.B., J.M.L.), Vanderbilt University Medical Center, Nashville, TN.
  8. Yale School of Medicine, New Haven, CT (N.J.B.).
  9. Department of Biostatistics, Vanderbilt School of Medicine (B.X.R, R.T.).
  10. Division of Genetic Medicine, Department of Medicine (M.M.S., J.N.H.), Vanderbilt University Medical Center, Nashville, TN.
  11. Division of Quantitative Sciences, Department of Obstetrics and Gynecology (D.R.V.E., A.G.), Vanderbilt University Medical Center, Nashville, TN.
  12. Department of Biomedical Informatics (D.R.V.E.), Vanderbilt University Medical Center, Nashville, TN.
  13. Institute of Medicine and Public Health (D.R.V.E., T.L.E.), Vanderbilt University Medical Center, Nashville, TN.
  14. Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville (C.L.R.).
  15. VA Palo Alto Health Care System (P.S.T.).
  16. Department of Medicine, Stanford University School of Medicine, CA (P.S.T.).
  17. Stanford Cardiovascular Institute (P.S.T.).
  18. VA Boston Healthcare System, MA (J.M.G.).
  19. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.G., C.J.O.).
  20. Epidemiology and Genomic Medicine, Atlanta VAMC, Decatur, GA (P.W.F.W.).
  21. Cardiology Division, Emory School of Medicine, Atlanta, GA (P.W.F.W.).
  22. VA Boston Healthcare System, Section of Cardiology (C.J.O.).
  23. Division of Epidemiology, Department of Medicine (T.L.E.), Vanderbilt University Medical Center, Nashville, TN.
  24. Memphis VA Medical Center, TN (C.P.K.).
  25. University of Tennessee Health Science Center, Memphis (C.P.K.).
  26. Vanderbilt Precision Nephrology Program (A.M.H.), Vanderbilt University Medical Center, Nashville, TN.

PMID: 34148359 PMCID: PMC8364328 DOI: 10.1161/HYPERTENSIONAHA.120.16181

Abstract

[Figure: see text].

Keywords: Treatment-resistant hypertension; apolipoprotein L1 variants; end-stage kidney disease; myocardial infarction; race; stroke

References

  1. Circulation. 2019 Sep 17;140(12):1031-1040 - PubMed
  2. Science. 2010 Aug 13;329(5993):841-5 - PubMed
  3. Kidney Int. 2015 Sep;88(3):622-32 - PubMed
  4. Hypertension. 2018 Nov;72(5):e53-e90 - PubMed
  5. Hypertension. 2015 Nov;66(5):998-1005 - PubMed
  6. Ann Intern Med. 2012 Nov 6;157(9):601-10 - PubMed
  7. Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):20-6 - PubMed
  8. N Engl J Med. 2013 Dec 5;369(23):2183-96 - PubMed
  9. Ann Intern Med. 2009 May 5;150(9):604-12 - PubMed
  10. Hypertension. 2016 Feb;67(2):387-96 - PubMed
  11. Circulation. 2018 Mar 20;137(12):e67-e492 - PubMed
  12. Am J Epidemiol. 2004 Dec 15;160(12):1137-46 - PubMed
  13. J Clin Epidemiol. 2016 Feb;70:214-23 - PubMed
  14. Am J Epidemiol. 1997 Apr 1;145(7):661-8 - PubMed
  15. Ann Intern Med. 2017 Nov 7;167(9):630-641 - PubMed
  16. JAMA. 1997 Apr 23-30;277(16):1293-8 - PubMed
  17. Am J Kidney Dis. 2014 May;63(5):781-8 - PubMed
  18. J Am Soc Hypertens. 2014 Jun;8(6):405-13 - PubMed
  19. Lancet. 2019 Oct 26;394(10208):1540-1550 - PubMed
  20. Hypertension. 2003 Dec;42(6):1206-52 - PubMed
  21. Am J Hypertens. 2003 Nov;16(11 Pt 1):925-30 - PubMed
  22. Kidney Int. 2012 Apr;81(7):698-706 - PubMed
  23. Ann Epidemiol. 2007 Mar;17(3):227-36 - PubMed
  24. JAMA. 2002 Nov 20;288(19):2421-31 - PubMed
  25. Hypertension. 2018 Jun;71(6):1269-1324 - PubMed
  26. Hypertension. 2011 Jun;57(6):1076-80 - PubMed
  27. N Engl J Med. 2010 Sep 2;363(10):918-29 - PubMed
  28. Hypertension. 2014 Nov;64(5):1012-21 - PubMed
  29. J Clin Hypertens (Greenwich). 2017 Nov;19(11):1117-1124 - PubMed
  30. J Am Soc Nephrol. 2017 Sep;28(9):2812-2823 - PubMed
  31. Am J Epidemiol. 1980 Oct;112(4):467-70 - PubMed
  32. N Engl J Med. 2015 Nov 26;373(22):2103-16 - PubMed

Publication Types

Grant support